Haiyuan Medical
Stage
IPO | IPODate of IPO
7/26/2018About Haiyuan Medical
Haiyuan Medical (NEEQ: 872891) focuses on the development of vitro diagnostic instruments and supporting reagents, bedside testing POCT products, and supporting test strips, and test card.
Missing: Haiyuan Medical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Haiyuan Medical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Haiyuan Medical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Haiyuan Medical is included in 1 Expert Collection, including Health Monitoring & Diagnostics.
Health Monitoring & Diagnostics
702 items
Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting
Haiyuan Medical Frequently Asked Questions (FAQ)
Where is Haiyuan Medical's headquarters?
Haiyuan Medical's headquarters is located at 5th to 7th Floor, Haipingyuan Production Factory, Guyuan Road No.229, Changsha.
What is Haiyuan Medical's latest funding round?
Haiyuan Medical's latest funding round is IPO.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.